92 related articles for article (PubMed ID: 3341786)
1. [Study on changes in plasma platinum concentrations after administration of CDDP to maintenance hemodialysis patients].
Suwata J; Hiraga S; Hida M; Takamiya T; Iida T; Sato T
Gan To Kagaku Ryoho; 1988 Feb; 15(2):243-8. PubMed ID: 3341786
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of cisplatin and vindesine in a patient with chronic renal failure undergoing hemodialysis].
Ayabe H; Uchikawa T; Kimino K; Tagawa Y; Kawahara K; Tomita M
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3283-5. PubMed ID: 2782920
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of cis-dichlorodiammine platinum (II) in patients undergoing hemodialysis].
Miyakawa M; Sugimoto K; Ohe Y; Masuoka H; Miyahara T
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2491-5. PubMed ID: 3619461
[TBL] [Abstract][Full Text] [Related]
4. [Combined 5-FU and CDDP in a gastric cancer patient undergoing hemodialysis--pharmacokinetics of 5-FU and CDDP].
Cho H; Imada T; Masudo K; Doi C; Inaba M; Tokunaga M; Takanashi Y
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2135-8. PubMed ID: 11103248
[TBL] [Abstract][Full Text] [Related]
5. [Intraperitoneal administration of anti-cancer drug with cisplatinum (CDDP)].
Hirahata S; Kumai K; Hurukawa T; Shimada A; Shibata S; Aizawa K; Matsui H; Takahara T; Shimizu H; Hukase T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1555-60. PubMed ID: 2389948
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. [Definitive end-stage chronic kidney failure after cisplatin treatment].
Brillet G; Deray G; Lucsko M; Faucher C; Aubert P; Rottembourg J; Jacobs C
Nephrologie; 1993; 14(5):227-9. PubMed ID: 8159252
[TBL] [Abstract][Full Text] [Related]
8. [Effects of combination chemotherapy with cis-diamminedichloroplatinum (II) (CDDP) on renal function in patients with urogenital malignancies].
Kawamura J; Hida S; Higashi Y; Yamauchi T; Soeda A; Yoshida O
Hinyokika Kiyo; 1985 Feb; 31(2):207-21. PubMed ID: 4040315
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of platinum accumulation in gastric cancer after preoperative intra-arterial injection of cisplatin].
Itoh A; Taniguchi H; Daidoh T; Tsukuda N; Shioaki Y; Seiki K; Yokota T; Yamane T; Yamaguchi T; Sawai K
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2722-5. PubMed ID: 2782884
[TBL] [Abstract][Full Text] [Related]
10. [Renal protection with amifostine during intraoperative peritoneal chemohyperthermia (IPCH) with cisplatin (CDDP) for peritoneal carcinosis. Phase 1 study].
Vaira M; Barone R; Aghemo B; Mioli PR; De Simone M
Minerva Med; 2001 Aug; 92(4):207-11. PubMed ID: 11535965
[TBL] [Abstract][Full Text] [Related]
11. [Superselective intra-arterial infusion chemotherapy of high-dose cisplatin for advanced paranasal sinus carcinomas].
Yokoyama J; Shiga K; Saijo S; Matumoto K; Ogawa Y
Gan To Kagaku Ryoho; 1999 Jun; 26(7):967-73. PubMed ID: 10396325
[TBL] [Abstract][Full Text] [Related]
12. [Distribution of cis-diamminedichloroplatinum in patients with metastatic brain tumors after intravenous or intracarotid administration].
Nakagawa H; Fujita T; Izumoto S; Kubo S; Nakajima Y; Turuzono K
Gan To Kagaku Ryoho; 1991 Jan; 18(1):103-9. PubMed ID: 1987891
[TBL] [Abstract][Full Text] [Related]
13. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of cisplatin and methotrexate in a patient suffering from advanced ureteral tumor accompanied by chronic renal failure, undergoing combined hemodialysis and systemic M-VAC chemotherapy].
Tokunaga J; Kikukawa H; Nishi K; Kitani K; Fujii J; Honda J; Wada Y; Ueda S; Nakano M
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2079-85. PubMed ID: 11103239
[TBL] [Abstract][Full Text] [Related]
15. A bioassay of cisplatin by human tumor clonogenic assay.
Sasaki Y; Saijo N; Lee YC; Takahashi H; Ishihara J; Sakurai M; Sano T; Nakano H; Kanzawa F; Hoshi A
Jpn J Cancer Res; 1986 May; 77(5):494-501. PubMed ID: 3089981
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline.
Bajorin DF; Bosl GJ; Alcock NW; Niedzwiecki D; Gallina E; Shurgot B
Cancer Res; 1986 Nov; 46(11):5969-72. PubMed ID: 3756934
[TBL] [Abstract][Full Text] [Related]
17. [Improvement in the regimen for combined CDDP and CPT-11 chemotherapy].
Shimizu A; Sugitoh Y; Hasegawa A; Okubo K; Fujihara T; Ishikawa T; Suzuki N; Yoda A; Narabayashi A; Takahashi J; Notake Y
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1807-11. PubMed ID: 11086417
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic evaluation of continuous infusion cisplatin].
Hiura M; Takenawa J; Ryoji O; Taki Y; Hyashi T; Kiriyama T
Hinyokika Kiyo; 1989 Jun; 35(6):955-61. PubMed ID: 2801396
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic evidence for the renal reabsorption of CDDP].
Kurose T; Sasaki T; Mochizuki M; Yasuda M; Yamazaki T; Sasagawa M; Tanaka K; Hando T
Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1229-37. PubMed ID: 2794646
[TBL] [Abstract][Full Text] [Related]
20. Plasma platinum elimination in a hemodialysis patient treated with cisplatin.
Gorodetsky R; Vexler A; Bar-Khaim Y; Biran H
Ther Drug Monit; 1995 Apr; 17(2):203-6. PubMed ID: 7624912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
